SCHEMBL11292593

SCHEMBL11292593

CCCCCCCC(CC)NC(=O)O

nearest known ligand 0.49

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
PLA2G2C Q5R387 2/20 0.49
GPR84 Q9NQS5 7/20 0.48
FFAR1 O14842 2/20 0.48
MAPT P10636 1/20 0.47
LCK P06239 1/20 0.47
PPARD Q03181 1/20 0.47
ZDHHC20 Q5W0Z9 1/20 0.47
ZDHHC2 Q9UIJ5 1/20 0.47
FFAR4 Q5NUL3 1/20 0.44
ACE2 Q9BYF1 1/20 0.44
PLA2G10 O15496 1/20 0.44
ZDHHC7 Q9NXF8 1/20 0.43
FAAH O00519 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28618729 1.00 PLA2G2C (0.49) PLA2G2CGPR84FFAR1MAPTLCK
SCHEMBL6154715 1.00 PLA2G2C (0.49) PLA2G2CGPR84FFAR1MAPTLCK
SCHEMBL27992370 1.00 PLA2G2C (0.49) PLA2G2CGPR84FFAR1MAPTLCK
SCHEMBL11168552 1.00 PLA2G2C (0.49) PLA2G2CGPR84FFAR1MAPTLCK
SCHEMBL27793369 1.00 PLA2G2C (0.49) PLA2G2CGPR84FFAR1MAPTLCK
SCHEMBL529507 0.98 PLA2G2C (0.46) PLA2G2CGPR84FFAR1MAPTLCK
Hydrochloric Acid SCHEMBL28811673 0.96 PLA2G2C (0.45) PLA2G2CGPR84FFAR1MAPTLCK
SCHEMBL20459159 0.92 PLA2G2C (0.56) PLA2G2CGPR84FFAR1MAPTLCK
SCHEMBL20459227 0.92 PLA2G2C (0.56) PLA2G2CGPR84FFAR1MAPTLCK
SCHEMBL9097264 0.92 PLA2G2C (0.56) PLA2G2CGPR84FFAR1MAPTLCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109563103-B Modulators of beta-3 adrenergic receptors for the treatment or prevention of disorders related thereto 艾尼纳制药公司 2022-05-27 CN disclosed
CN-111699189-A Modulators of beta-3 adrenergic receptors useful for the treatment or prevention of heart failure and disorders associated therewith 艾尼纳制药公司 2020-09-22 CN disclosed
US-4336402-A Process for the preparation of N-alkyl-monosubstituted carbamic acid esters ATLANTIC RICHFIELD COMPANY (US) 1982-06-22 US disclosed